Marc Casper, Thermo Fisher CEO (Suzanne Kreiter/The Boston Globe via Getty Images)

Ther­mo Fish­er wa­gers on ear­ly can­cer di­ag­nos­tics in $2.6B cash deal for mul­ti­ple myelo­ma test mak­er

Al­ways on the look­out for the next thing to buy, Ther­mo Fish­er Sci­en­tif­ic has set­tled on an on­col­o­gy di­ag­nos­tic play­er for its lat­est ac­qui­si­tion. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.